Event

Asian Investment Series 2018

AusBiotech



Register

About the Event

AusBiotech’s Global Investment Event Series helps Australian life sciences companies connect with global capital markets and empowers them to be competitive on a global scale by:

  • Leading Australian life sciences companies to major investment hubs around the world including Australia, Hong Kong, China, the US and Europe.
  • Arranging access to opportunities for collaboration, partnerships and alternative funding.
  • Providing investor support and education both domestically and internationally.

The AusBiotech-led Global Investment Program aims to improve management and workforce skills. AusBiotech is working with consortium partners the ASX, DibbsBarker, WE Buchan and KPMG, all of which bring extensive insight and experience in the life sciences to enhance the capability of the sector to engage with international markets and access global supply chains.

This venture has received funding through the MTPConnect Project Fund Program – a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sector, supported by the Australian Government Industry Growth Centres Initiative.